Simulect
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0078-0331 -
Package NDC
0078-0331-84 -
Application number
BLA103764 -
SPL ID
ef891000-2e11-4c42-bbb7-7c3fb3180b02 -
SPL set ID
1af01887-b69d-444b-91ed-ebfe12784440 -
UNII
9927MT646M -
RxCUI
1656643 -
RxCUI
1656646 -
RxCUI
1656648 -
RxCUI
1656650
What the source publishes
- Labeler
- Novartis Pharmaceuticals Corporation
- Active ingredients
- basiliximab
- Form
- INJECTION, POWDER, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Simulect",
"splId": "ef891000-2e11-4c42-bbb7-7c3fb3180b02",
"labels": [
{
"setId": "1af01887-b69d-444b-91ed-ebfe12784440",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1af01887-b69d-444b-91ed-ebfe12784440",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1af01887-b69d-444b-91ed-ebfe12784440"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Novartis Pharmaceuticals Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-USE in 1 CARTON (0078-0331-84) / 5 mL in 1 VIAL, SINGLE-USE",
"package_ndc": "0078-0331-84",
"identifierStatus": "well-formed",
"marketing_start_date": "19980512"
}
],
"productId": "0078-0331_ef891000-2e11-4c42-bbb7-7c3fb3180b02",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, FOR SOLUTION",
"productNdc": "0078-0331",
"deaSchedule": null,
"genericName": "basiliximab",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BASILIXIMAB",
"strength": "20 mg/5mL"
}
],
"applicationNumber": "BLA103764",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "19980512",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000010279",
"N0000175621",
"N0000175622"
],
"unii": [
"9927MT646M"
],
"rxcui": [
"1656643",
"1656646",
"1656648",
"1656650"
],
"spl_set_id": [
"1af01887-b69d-444b-91ed-ebfe12784440"
],
"pharm_class_epc": [
"Interleukin-2 Receptor Blocking Antibody [EPC]"
],
"pharm_class_moa": [
"Interleukin 2 Receptor Antagonists [MoA]",
"Interleukin 2 Receptor-directed Antibody Interactions [MoA]"
],
"manufacturer_name": [
"Novartis Pharmaceuticals Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0078-0331_ef891000-2e11-4c42-bbb7-7c3fb3180b02"